These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 8619584
1. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Perdikaris G, Giamarellou H, Pefanis A, Donta I, Karayiannakos P. Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584 [Abstract] [Full Text] [Related]
6. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. Bayer AS, Lam K. J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588 [Abstract] [Full Text] [Related]
8. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus. Madrigal AG, Basuino L, Chambers HF. Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918 [Abstract] [Full Text] [Related]
10. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci. Ramos MC, Ing M, Kim E, Witt MD, Bayer AS. Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887 [Abstract] [Full Text] [Related]
12. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis. Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I, Pelekanou A, Giamarellos-Bourboulis EJ, Giamarellou H, Kanellakopoulou K. J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576 [Abstract] [Full Text] [Related]
17. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Marco F, de la Mària CG, Armero Y, Amat E, Soy D, Moreno A, del Río A, Almela M, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM, Hospital Clinic Experimental Endocarditis Study Group. Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900 [Abstract] [Full Text] [Related]
18. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C. Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757 [Abstract] [Full Text] [Related]